Brief: Race Oncology Says Signed Clinical Trial Collaboration And Supply Deal With Astex Pharmaceuticals
30/03/2022 07:40
March 30 (Reuters) - Race Oncology Ltd RAC.AX :
* SIGNED CLINICAL TRIAL COLLABORATION AND SUPPLY AGREEMENT
WITH
ASTEX PHARMACEUTICALS
* DEAL TO SUPPLY ASTX727 FOR CO'S EXTRAMEDULLARY ACUTE
MYELOID
LEUKAEMIA & MYELODYSPLASTIC SYNDROME STUDY, RAC-006
Source text for Eikon: ID:nASX6SLC7Q
Further company coverage: RAC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Racura Oncology
See all newsAustralia's Racura Oncology jumps most in a month after raising $24 million
Brief: Racura Oncology Says Emerging Companies Specialist Invests In Racura
Brief: Racura Oncology Announces Positive Safety Review Committee Recommendation In Ongoing Cpacs Clinical Trial
Australia's Racura Oncology gains on Purdue University cancer study collab
Brief: Racura Oncology Receives Governance Approval For Harness-1 Phase 1 Trial Of Rc220